問卷

TPIDB > Search Result

Search Result

篩選

List

8Cases

2025-06-30 - 2027-07-28

Phase III

Active
A multicenter, randomized, double-blind, placebo-controlled, parallel-group trial was conducted to evaluate the efficacy and safety of lebrikizumab in adult and adolescent participants with moderate to severe atopic dermatitis of the hands and feet.
  • Condition/Disease

    Moderate to severe atopic dermatitis of the hands and feet

  • Test Drug

    EBGLYSS Injection

Participate Sites
7Sites

Recruiting7Sites

2024-09-01 - 2028-09-30

Phase II

Active
  • Condition/Disease

  • Test Drug

Participate Sites
2Sites

Recruiting2Sites

2024-09-01 - 2028-09-30

Phase II

Active
  • Condition/Disease

  • Test Drug

Participate Sites
2Sites

Recruiting2Sites

2021-11-01 - 2025-12-31

Phase III

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
9Sites

Recruiting8Sites

Terminated1Sites

2024-01-01 - 2027-05-31

Phase II

Active
  • Condition/Disease

  • Test Drug

Participate Sites
10Sites

Not yet recruiting2Sites

Recruiting8Sites

2023-07-31 - 2026-05-27

Completed
  • Condition/Disease

  • Test Drug

Participate Sites
8Sites

Recruiting8Sites

2025-07-18 - 2029-12-31

Phase II

Active
  • Condition/Disease

  • Test Drug

Participate Sites
4Sites

Recruiting4Sites

2023-07-31 - 2026-05-27

Phase II

  • Condition/Disease

  • Test Drug

Participate Sites
8Sites

Recruiting8Sites